Skip to main content
SpringerLink
Log in

Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences

  • Review
  • Published:
Urolithiasis Aims and scope Submit manuscript

Abstract

Diabetes and obesity are already recognized as potential risk factors for nephrolithiasis, especially for uric acid stones. Insulin resistance and hyperinsulinemia actively contribute to impaired ability to excrete an acid load and altered ammonium production, leading to a lower urinary pH compared to non-diabetic controls. All these electrolytic disorders play an important role in stone formation and aggregation, especially in uric acid stones. There are still missing points in scientific evidence if the increased risk in stone formation is already existing even in the prediabetic statuses (isolated impaired glucose tolerance, isolated impaired fasting glucose, and associated impaired glucose tolerance/impaired fasting glucose) as well as it is worth to consider the same level of risk. Urolithiasis is the most frequent urological cause of hospitalization in diabetic patients and its cost is usually higher compared to non-diabetic patients, but less is known in others altered glycaemic diseases. The aim of this review article is to focus on the association between stone formation and altered glycaemic statuses, beyond the already known link between nephrolithiasis and diabetes mellitus.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Pearle MS, Calhoun EA, Curhan GC (2005) Urologic diseases in America project: urolithiasis. J Urol 173(3):848–857

    Article  PubMed  Google Scholar 

  2. Antonelli JA, Maalouf NM, Pearle MS et al (2014) Use of the National Health and Nutrition Examination Survey to calculate the impact of obesity and diabetes on cost and prevalence of urolithiasis in 2030. Eur Urol 66(4):724–729

    Article  PubMed  PubMed Central  Google Scholar 

  3. Taylor EN, Stamper MJ, Curhan GC (2005) Diabetes mellitus and the risk of nephrolithiasis. Kidney Int 68:1230–1235

    Article  PubMed  Google Scholar 

  4. Scales CD Jr, Smith AC, Hanley JM et al (2012) Urological disease in America P. Prevalence of kidney stones in the United States. Eur Urol 62(1):160–165

    Article  PubMed  PubMed Central  Google Scholar 

  5. Daudon M, Traxer O, Conort P et al (2006) Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol 17:2026–2033

    Article  CAS  PubMed  Google Scholar 

  6. Cameron MA, Maalouf NM, Adams-Huet B et al (2006) Urine composition in type 2 diabetes: predisposition to uric acid nephrolithiasis. J Am Soc Nephrol 17:1422–1428

    Article  CAS  PubMed  Google Scholar 

  7. Chobanian MC, Hammermann MR (1987) Insulin stimulates ammoniagenesis in canine renal proximal tubular segments. Am J Physiol 253:F1171–F1177

    CAS  PubMed  Google Scholar 

  8. Bell DS (2012) Beware the low urine pH-the major cause of increased prevalence of nephrolithiasis in the patient with type 2 diabetes. Diabetes Obes Metab 14:299–303

    Article  CAS  PubMed  Google Scholar 

  9. Hartman C, Friedlander JI, Moreira DM (2015) Differences in 24-h urine composition between nephrolithiasis patients with and without diabetes mellitus. BJU Int 115:619–624

    Article  CAS  PubMed  Google Scholar 

  10. Nerli R, Jali M, Guntaka AK et al (2015) Type 2 diabetes mellitus and renal stones. Adv Biomed Res 4:180

    PubMed  PubMed Central  Google Scholar 

  11. Jeong IG, Kang T, Bang JK et al (2011) Association between metabolic syndrome and the presence of kidney stones in a screened population. Am J Kidney Dis 58:383–388

    Article  PubMed  Google Scholar 

  12. Sakhaee K (2008) Nephrolithiasis as a systemic disorder. Curr Opin Nephrol Hypertens 17:304–309

    Article  PubMed  Google Scholar 

  13. Gambaro G, Croppi E, Coe F et al (2016) Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol 29(6):715–734

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Sakhaee K (2009) Recent advances in the pathophysiology of nephro-lithiasis. Kidney Int 75:585–595

    Article  CAS  PubMed  Google Scholar 

  15. Ferraro PM, Taylor EN, Eisner BH et al (2013) History of kidney stones and the risk of coronary heart disease. JAMA 310(4):408–415

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Rendina D, De Filippo G, D’Elia L et al (2014) Metabolic syndrome and nephrolithiasis: a systematic review and meta-analysis of the scientific evidence. J Nephrol 27(4):371–376

    CAS  PubMed  Google Scholar 

  17. Cho ST, Jung SI, Myung SC et al (2013) Correlation of metabolic syndrome with urinary stone composition. Int J Urol 20:208–213

    Article  CAS  PubMed  Google Scholar 

  18. Rendina D, Mossetti G, De Filippo G et al (2009) Association between metabolic syndrome and nephrolithiasis in an inpatient population in Southern Italy: role of gender, hypetension and abdominal obesity. Nephron Dial Transplant 24:900–906

    Article  Google Scholar 

  19. Kabeya Y, Kato K, Tomita M et al (2012) Associations of insulin resistance and glycemic control with the risk of kidney stones. Intern Med 51:699–705

    Article  CAS  PubMed  Google Scholar 

  20. Strohamaier WL, Wrobel BM, Schubert G (2012) Overweight, insulin resistance and blood pressure (parameters of the metabolic syndrome) in uric acid urolithiasis. Urol Res 40:171–175

    Article  Google Scholar 

  21. Lien T-H, Wu J-S, Yang Y-C et al (2016) The effect of glycaemic status on kidney stone disease in patient with prediabetes. Diabetes Metab J 40:161–166

    Article  PubMed  PubMed Central  Google Scholar 

  22. Jung HS, Chang IH, Kim KD et al (2011) Possible relationship between metabolic syndrome traits and nephrolithiasis: incidence for 15 years according to gender. Kor J Urol 52:548–553

    Article  Google Scholar 

  23. Abdul-Ghani MA, Jenkinson CP, Richardson DK et al (2006) Insulin secretion and action in subjects with im-paired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study. Diabetes 55:1430–1435

    Article  CAS  PubMed  Google Scholar 

  24. Nagasaka S, Murakami T, Uchikawa T et al (1995) Effect of glycemic control on calcium and phosphorus handling and parathyroid hormone level in patients with non-insulin-dependent diabetes mellitus. Endocr J 42:377–383

    Article  CAS  PubMed  Google Scholar 

  25. Thalassinos NC, Hadjiyanni P, Tzanela M et al (1993) Calcium metabolism in diabetes mellitus: effect of improved blood glucose control. Diabet Med 10:341–344

    Article  CAS  PubMed  Google Scholar 

  26. Cook DG, Shaper AG, Thelle DS et al (1986) Serum uric acid, serum glucose and diabetes: relationships in a population study. Postgrad Med J 62:1001–1006

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Chang IH, Lee YT, Lee DM et al (2011) Metabolic syndrome, urine pH, and time-dependent risk of nephrolithiasis in Korean men. Urology 78(4):753–758

    Article  PubMed  Google Scholar 

  28. Verde I, Rusu E, Suliman E et al (2015) Diabetes in the hospitalized patients with urological diseases. J Med Life 8(4):496–501

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Nephrology, Humanitas Clinical and Research Center, via Manzoni 56, 20089, Rozzano, MI, Italy

    Leonardo Spatola, Claudio Angelini & Salvatore Badalamenti

  2. Division of Paediatric Nephrology, Ospedale “G. Di Cristina”, Piazza Porta Montalto 2, 90134, Palermo, PA, Italy

    Silvio Maringhini

  3. Division of Nephrology, Policlinico Universitario “Agostino Gemelli”, Largo Agostino Gemelli 8, 00168, Rome, RM, Italy

    Giovanni Gambaro

Authors
  1. Leonardo Spatola
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Claudio Angelini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Salvatore Badalamenti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Silvio Maringhini
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Giovanni Gambaro
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leonardo Spatola.

Ethics declarations

Conflict of interest

All the authors declare to not have any conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Spatola, L., Angelini, C., Badalamenti, S. et al. Kidney stones diseases and glycaemic statuses: focus on the latest clinical evidences. Urolithiasis 45, 457–460 (2017). https://doi.org/10.1007/s00240-016-0956-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00240-016-0956-8

Keywords

Search

Navigation